TNF in the inflammatory response.
Männel
D N
DN
Institut für Pathologie, Tumorimmunologie, Universität Regensburg, Deutschland. daniela.maennel@klinik.uni-regensburg.de
Echtenacher
B
B
D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000378:metabolism; D001777:Blood Coagulation / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D002908:Chronic Disease; D003165:Complement System Proteins / Q000502:physiology; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000276:immunology; D008407:Mast Cells / Q000378:metabolism; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D016513:Mice, SCID; D009369:Neoplasms / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D010215:Papio; D010538:Peritonitis / Q000188:drug therapy / Q000378:metabolism; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology; D012772:Shock, Septic / Q000188:drug therapy / Q000378:metabolism; D013329:Structure-Activity Relationship; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000502:physiology*
D008070:Lipopolysaccharides; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D003165:Complement System Proteins